OSTEOLOGIX AS has a total of 51 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ACTION MEDICINES SL, PITNEY PHARMACEUTICALS PTY LTD and SYNDROMEX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | Australia | 10 | |
#3 | Canada | 8 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Japan | 4 | |
#6 | United States | 4 | |
#7 | Hong Kong | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Brazil | 1 | |
#10 | China | 1 | |
#11 | Norway | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Christgau Stephan | 41 |
#2 | Nilsson Henrik | 35 |
#3 | Hansen Christian | 35 |
#4 | Andersen Jens E T | 26 |
#5 | Christgau Stephen | 6 |
#6 | Bone Henry G Iii | 5 |
#7 | Stephan Christgau | 3 |
#8 | Andersen Jens | 2 |
#9 | Christian Hansen | 1 |
#10 | Henrik Nilsson | 1 |
Publication | Filing date | Title |
---|---|---|
AU2006265491A1 | High yield synthesis methods for producing organic salts of strontium | |
CN101218219A | High yield synthesis methods for producing organic salts of strontium | |
EP1855654A1 | Tablets comprising a high load of strontium | |
EP1758652A2 | Improving pain treatment with strontium combinations | |
EP1758653A2 | Treatments comprising strontium for rheumatic and arthritic diseases and pain | |
AU2005240257A1 | High yield and rapid syntheses methods for producing metallo-organic salts | |
CA2557324A1 | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions | |
EP1622630A2 | Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions | |
WO2004098617A2 | Controlled release composition containing a strontium salt | |
CA2519189A1 | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |